OTCMKTS:SVNTQ - Savient Pharmaceuticals Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started Previous Close$0.0019Today's RangeN/A52-Week RangeN/AVolumeN/AAverage Volume340,036 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionChartEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Savient Pharmaceuticals, Inc. (Savient), incorporated in 1980, is a specialty biopharmaceutical company focused on commercializing KRYSTEXXA (pegloticase) in the United States and completing the development and seeking regulatory approval outside of the United States for KRYSTEXXA, particularly in the European Union. The Company also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. In October 2013, the Company announced that it has elected to file voluntary petitions under Chapter 11 of the Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware (the Court). Effective January 10, 2014, Crealta Pharmaceuticals LLC, a majority owned unit of GTCR LLC acquired Savient Pharmaceuticals Inc. Receive SVNTQ News and Ratings via Email Sign-up to receive the latest news and ratings for SVNTQ and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry N/A Sub-IndustryN/A SectorN/A Current SymbolOTCMKTS:SVNTQ Previous SymbolNASDAQ:SVNT CUSIPN/A Webwww.savientpharma.com Phone+1-732-4189300Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A OptionableNot Optionable Savient Pharmaceuticals (OTCMKTS:SVNTQ) Frequently Asked Questions What is Savient Pharmaceuticals' stock symbol? Savient Pharmaceuticals trades on the OTCMKTS under the ticker symbol "SVNTQ." Has Savient Pharmaceuticals been receiving favorable news coverage? News coverage about SVNTQ stock has trended very positive recently, InfoTrie reports. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Savient Pharmaceuticals earned a media sentiment score of 3.7 on InfoTrie's scale. They also gave news stories about the biopharmaceutical company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an impact on the stock's share price in the next few days. How do I buy shares of Savient Pharmaceuticals? Shares of SVNTQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Savient Pharmaceuticals' official website? The official website for Savient Pharmaceuticals is http://www.savientpharma.com/. How can I contact Savient Pharmaceuticals? Savient Pharmaceuticals' mailing address is 1 Tower Center Blvd, EAST BRUNSWICK, NJ 08816-1145, United States. The biopharmaceutical company can be reached via phone at +1-732-4189300. MarketBeat Community Rating for Savient Pharmaceuticals (OTCMKTS SVNTQ)Community Ranking: 2.0 out of 5 ( )Outperform Votes: 66 (Vote Outperform)Underperform Votes: 96 (Vote Underperform)Total Votes: 162MarketBeat's community ratings are surveys of what our community members think about Savient Pharmaceuticals and other stocks. Vote "Outperform" if you believe SVNTQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SVNTQ will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/23/2019 by MarketBeat.com StaffFeatured Article: What are no-load funds?